u.s innovation award, page-6

BOT,

we've certainly seen some reshaping of the shareholder base thisweek. volumes have been strong and shareprice holding above that now crucial .025 level. would have thoguht .05 is a doddle if they really decide to push it.

given they have three more quarterly reports to give us before the oppies expire i can only imagine what the revenue trend line is going to look like come mid 2011. i would have thought that at some stage in the next six months they receive the sort of order that proves the business plan will pan out eaxactly as they hope it will. ie: resmed +++

also, wondering your thoughts on potential to be a takeover target. is this a real risk yet ... or is it likely to be a lot further down the track? strikes me that resmed and others must be watching this mob very closely, and would know exactly how good the tech is. surely they will not wait for this to be a $100m ++ company before scooping it up.

thoughts, charts welcome